MX365375B - Composiciones de diclofenaco. - Google Patents

Composiciones de diclofenaco.

Info

Publication number
MX365375B
MX365375B MX2015008369A MX2015008369A MX365375B MX 365375 B MX365375 B MX 365375B MX 2015008369 A MX2015008369 A MX 2015008369A MX 2015008369 A MX2015008369 A MX 2015008369A MX 365375 B MX365375 B MX 365375B
Authority
MX
Mexico
Prior art keywords
diclofenac
composition
present
diclofenac composition
articular
Prior art date
Application number
MX2015008369A
Other languages
English (en)
Other versions
MX2015008369A (es
Inventor
Dinesh Shantilal Patel
Sachin Dinesh Patel
Shashikant Prabhudas Kurani
Madhavlal Govindlal Patel
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX365375(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Publication of MX2015008369A publication Critical patent/MX2015008369A/es
Publication of MX365375B publication Critical patent/MX365375B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición que comprende diclofenaco y sales del mismo, en la que el diclofenaco o sus sales están presentes en una cantidad de 25 a 200 mg. La composición es adecuada para la administración parenteral por vía intramuscular, pintravenosa; también para administración oral, dérmica, subcutánea, cutánea, nasal, gotas oftálmicas, así como supositorios rectales, óvulos vaginales, administración intraarticular y ótica. La invención también proporciona composiciones que comprenden una combinación de diclofenaco y otros principios activos. La invención también proporciona un método para preparar la composición.
MX2015008369A 2012-12-28 2013-12-27 Composiciones de diclofenaco. MX365375B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28
PCT/IN2013/000805 WO2014102824A1 (en) 2012-12-28 2013-12-27 Diclofenac composition

Publications (2)

Publication Number Publication Date
MX2015008369A MX2015008369A (es) 2016-03-01
MX365375B true MX365375B (es) 2019-05-31

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008369A MX365375B (es) 2012-12-28 2013-12-27 Composiciones de diclofenaco.

Country Status (25)

Country Link
US (1) US20140187635A1 (es)
EP (1) EP2938325B8 (es)
JP (1) JP6117939B2 (es)
KR (1) KR101730284B1 (es)
CN (1) CN104968331A (es)
AP (1) AP2015008534A0 (es)
AU (1) AU2013368849B2 (es)
BR (1) BR112015015699B1 (es)
CL (1) CL2015001869A1 (es)
EA (1) EA035079B1 (es)
ES (1) ES2721400T3 (es)
HK (1) HK1211858A1 (es)
HU (1) HUE045030T2 (es)
IL (1) IL239395A0 (es)
MA (1) MA38292A1 (es)
MX (1) MX365375B (es)
MY (1) MY184886A (es)
PE (1) PE20151208A1 (es)
PH (1) PH12015501479A1 (es)
SG (1) SG11201504577UA (es)
SI (1) SI2938325T1 (es)
TR (1) TR201905806T4 (es)
UA (1) UA114123C2 (es)
WO (1) WO2014102824A1 (es)
ZA (1) ZA201504258B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
US11744899B2 (en) * 2018-11-16 2023-09-05 Seikagaku Corporation Pharmaceutical composition containing a hyaluronic acid derivative
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
EP4106724A1 (en) * 2020-02-18 2022-12-28 Novo Nordisk A/S Glp-1 compositions and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
EP0661050A1 (en) * 1991-07-04 1995-07-05 Taisho Pharmaceutical Co. Ltd Analgesic
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
AU2004226323A1 (en) * 2003-03-26 2004-10-14 Becton, Dickinson And Company Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
US20050137164A1 (en) 2003-09-22 2005-06-23 Moshe Arkin Diclofenac compositions for the treatment of skin disorders
DK1767219T3 (da) 2004-03-10 2010-05-10 Shimoda Biotech Pty Ltd Stabile injicerbare diclofenac-sammensætninger
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
AP2888A (en) * 2005-02-01 2014-05-31 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
MX2007014862A (es) * 2005-05-27 2008-02-21 Panacea Biotec Ltd Composiciones inyectables y procedimiento para la preparacion de dichas composiciones.
EP2364140A1 (en) 2008-11-28 2011-09-14 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester

Also Published As

Publication number Publication date
IL239395A0 (en) 2015-07-30
UA114123C2 (xx) 2017-04-25
EP2938325A1 (en) 2015-11-04
MX2015008369A (es) 2016-03-01
PH12015501479B1 (en) 2015-09-21
JP2016508139A (ja) 2016-03-17
MA38292A1 (fr) 2017-06-30
PH12015501479A1 (en) 2015-09-21
WO2014102824A8 (en) 2014-10-02
CL2015001869A1 (es) 2015-10-23
EA035079B1 (ru) 2020-04-24
PE20151208A1 (es) 2015-08-23
HUE045030T2 (hu) 2019-12-30
WO2014102824A1 (en) 2014-07-03
EA201591230A1 (ru) 2015-11-30
BR112015015699A2 (pt) 2017-07-11
EP2938325B1 (en) 2019-04-10
US20140187635A1 (en) 2014-07-03
BR112015015699B1 (pt) 2022-09-27
ZA201504258B (en) 2016-04-28
SI2938325T1 (sl) 2019-06-28
KR20150090250A (ko) 2015-08-05
TR201905806T4 (tr) 2019-05-21
AP2015008534A0 (en) 2015-06-30
HK1211858A1 (en) 2016-06-03
AU2013368849B2 (en) 2017-01-12
ES2721400T3 (es) 2019-07-31
KR101730284B1 (ko) 2017-04-25
JP6117939B2 (ja) 2017-04-19
CN104968331A (zh) 2015-10-07
SG11201504577UA (en) 2015-07-30
EP2938325B8 (en) 2019-09-25
AU2013368849A1 (en) 2015-07-09
ES2721400T8 (es) 2019-10-10
MY184886A (en) 2021-04-29

Similar Documents

Publication Publication Date Title
PH12015501479A1 (en) Diclofenac composition
MX2022007264A (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
NZ631537A (en) Compositions and methods for modulating apolipoprotein c-iii expression
MX349162B (es) Sistemas de deposito que comprende glatiramer o una sal farmacologicamente aceptable del mismo.
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
TN2012000369A1 (en) 5-alkynyl-pyrimidines
NZ709958A (en) Enhanced stability of novel liquid compositions
UA114656C2 (uk) Похідні піридину
WO2013067199A3 (en) Subcutaneous delivery of polymer conjugates of therapeutic agents
PH12016501879A1 (en) Immunological composition containing attenuated histophilus somni
MX340233B (es) Agonistas de receptores de neurotrofina y sus usos como medicamentos.
PH12014502571A1 (en) Ophthalmic compositions with improved dessication protection and retention
MY171201A (en) New carbamate glycolipid and use thereof
MD20140123A2 (ro) Agenţi terapeutici optimizaţi pentru administrare subcutanată
BR112014002173A2 (pt) proteínas purificadas
MX337464B (es) Profarmacos lipofilicos labiles al acido de los agentes quimioterapeuticos contra el cancer.
MX2016003238A (es) Composiciones antisepticas cationicas.
MY160383A (en) Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
MX2012006265A (es) Formulaciones disacaridas hipersulfatadas.
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
WO2014093818A3 (en) Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
MX2013015381A (es) Formulaciones de suministro de farmaco.
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
SA112330437B1 (ar) تركيبات دوائية محتوية على عامل منوم او مخدر وطريقة تحضيرها
TH162682B (th) องค์ประกอบไดโคลฟีแนค

Legal Events

Date Code Title Description
FG Grant or registration